Imfinzi-Chemo Combo Shows Effectiveness in Treating Triple-negative Breast Cancer, Phase 2 Study Shows
News
The combination of Imfinzi (durvalumab) with standard chemotherapy leads to high treatment effectiveness in patients with triple-negative breast cancer (TNBC), a Phase 2 trial shows. The research, “Randomized phase II ... Read more